Retatrutide
Triple agonist peptide (GLP-1/GIP/Glucagon) investigated for metabolic research.
Specifications
| Size | 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 120mg |
Description
Research Overview
Retatrutide (LY3437943) is a novel triple-acting agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies.
Specifications
- Form: Lyophilized powder
- Storage: Store the powder refrigerated (2–8°C) or frozen, protected from light and moisture, until the printed expiry. After reconstitution, keep refrigerated (do not freeze); full potency ~1 month, with a noticeable quality drop after ~6 weeks.
For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.
Certificate of Analysis (Janoshik)
Independent third-party testing by Janoshik Analytical. Click to view full report.
All products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. By purchasing, you agree to our research policy and confirm you are a qualified researcher.